TY  - RPRT
TI  - Novel MBLs inhibitors screened from FDA-approved drug library restore the susceptibility of carbapenems to NDM-1-harbouring bacteria
AU  - Guo, Y.
AU  - Liu, H.
AU  - Yang, M.
AU  - Ding, R.
AU  - Gao, Y.
AU  - Niu, X.
AU  - Deng, X.
AU  - Wang, J.
AU  - Feng, H.
AU  - Qiu, J.
PY  - 2022
DO  - 10.1101/2022.01.16.476523
UR  - https://www.biorxiv.org/content/10.1101/2022.01.16.476523v1
ID  - 10.1101/2022.01.16.476523
ER  -